Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Serum Copper and Zinc Status Assessed in Patients

By LabMedica International staff writers
Posted on 24 Sep 2009
A diagnostic test panel is designed to assess the metabolic serum copper and zinc status of patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI).

Defects in copper metabolism and high free copper levels are increasingly being recognized as significant factors in the progression of neurodegenerative diseases, including AD and MCI. More...
A clinical zinc deficiency in AD patients has also been recognized for the first time in a recent clinical study.

The diagnostic panel will be offered through Adeona Pharmaceuticals Inc. (Ann Arbor, MI, USA) subsidiary, Hartlab LLC--a Clinical Laboratory Improvement Amendments (CLIA)-certified clinical reference laboratory. Initial marketing efforts will target neurologists, psychiatrists, gerontologists, nursing homes, and other physicians and institutions that regularly treat patients with these neurodegenerative conditions.

Max Lyon, Adeona's CEO, stated, "We consider chronic copper toxicity to be a significantly under-recognized and modifiable risk factor for the progression of AD and MCI. We have also recently completed the first international epidemiological study finding a correlation between copper plumbing tube use and the rates of prevalence of Alzheimer's disease by country and believe that such study lends further support to the growing body of evidence that chronic inorganic copper exposure plays an important role in the progression of Alzheimer's disease. Using Adeona's proprietary, modified oral zinc delivery technologies, Adeona is preparing to initiate the first clinical trial of oral zinc therapy for the once-a-day dietary management of AD and MCI."

Adeona Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to the awareness, diagnosis, prevention, and treatment of zinc deficiency and chronic copper toxicity in adults. The company believes that these conditions may contribute to the progression of debilitating degenerative diseases, including dry age-related macular degeneration (dry AMD), Alzheimer's disease (AD), and mild cognitive impairment (MCI) in susceptible persons.

Related Links:
Adeona Pharmaceuticals Inc.




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.